Catalyst Wire Dossier Catalyst Wire Dossier

Fostamatinib disodium

fostamatinib disodium · Rigel Pharmaceuticals
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Fostamatinib disodium, covering 2014-06-12 to 2023-05-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA [Phase 3]

See pricing